Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Eribis Pharmaceuticals AB
AB
Active
Org 5567013221
Kåbovägen 10, 752 36
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2006 · 20 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Eribis Pharmaceuticals AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CH
Carl Herman Krapf
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
SM
Siv Marianne Johansson
Deputy Board Member
Deputy Board Member
2022
CH
Carl Herman Krapf
Chairman
Chairman
2022
SM
Siv Maria Kristina Krapf
Board of Directors
Board of Directors
2022
Former (1)
IB
Irina Bobrova
Board of Directors
Board of Directors
2023 – 2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Eribis Pharmaceuticals AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
